Literature DB >> 17470333

Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies.

Mobusher Mahmud1, Hunter C Champion.   

Abstract

Right heart failure most commonly results from the complication of left heart failure (systolic or nonsystolic dysfunction) or pulmonary hypertension. Over the past decade, greater attention has been paid to the role of right ventricular failure in the morbidity and mortality associated with cardiomyopathy and pulmonary hypertension. The right ventricle is distinct from the left ventricle not only in its spatial localization, but also in its response to increased afterload and signaling mechanisms. This article discusses the role of right ventricular failure in the setting of heart failure as well as the clinical diagnosis and management of right ventricular failure.

Entities:  

Mesh:

Year:  2007        PMID: 17470333     DOI: 10.1007/bf02938351

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  96 in total

1.  The usefulness of pulsed tissue Doppler for the clinical assessment of right ventricular function.

Authors:  Maurizio Galderisi; Sergio Severino; Silvana Cicala; Pio Caso
Journal:  Ital Heart J       Date:  2002-04

2.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors:  T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

3.  Tricuspid annular displacement predicts survival in pulmonary hypertension.

Authors:  Paul R Forfia; Micah R Fisher; Stephen C Mathai; Traci Housten-Harris; Anna R Hemnes; Barry A Borlaug; Elzbieta Chamera; Mary C Corretti; Hunter C Champion; Theodore P Abraham; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2006-08-03       Impact factor: 21.405

4.  Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.

Authors:  Stefan Klotz; Alessandro Barbone; Steven Reiken; Jeffrey W Holmes; Yoshifumi Naka; Mehmet C Oz; Andrew R Marks; Daniel Burkhoff
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

5.  Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study.

Authors:  Milton Packer; John McMurray; Barry M Massie; Abraham Caspi; Vincent Charlon; Alain Cohen-Solal; Wolfgang Kiowski; William Kostuk; Henry Krum; Barry Levine; Paolo Rizzon; Jordi Soler; Karl Swedberg; Susan Anderson; David L Demets
Journal:  J Card Fail       Date:  2005-02       Impact factor: 5.712

6.  Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.

Authors:  Gregory D Lewis; Christian Witzke; Pedro Colon-Hernandez; J Luis Guerrero; Kenneth D Bloch; Marc J Semigran
Journal:  J Am Coll Cardiol       Date:  2006-03-20       Impact factor: 24.094

7.  Neurohumoral and hemodynamic effects of the selective endothelin antagonist darusentan in advanced chronic heart failure.

Authors:  Jutta Bergler-Klein; Richard Pacher; Rudolf Berger; Anda Bojic; Brigitte Stanek
Journal:  J Heart Lung Transplant       Date:  2004-01       Impact factor: 10.247

Review 8.  Tezosentan in the treatment of acute heart failure.

Authors:  John M Tovar; John G Gums
Journal:  Ann Pharmacother       Date:  2003-12       Impact factor: 3.154

9.  MRI evaluation of right ventricular pressure overload in chronic obstructive pulmonary disease.

Authors:  J T Marcus; A Vonk Noordegraaf; P M De Vries; A C Van Rossum; B Roseboom; R M Heethaar; P E Postmus
Journal:  J Magn Reson Imaging       Date:  1998 Sep-Oct       Impact factor: 4.813

10.  Early effects of oxygen administration and prognosis in chronic obstructive pulmonary disease and cor pulmonale.

Authors:  K Ashutosh; G Mead; M Dunsky
Journal:  Am Rev Respir Dis       Date:  1983-04
View more
  9 in total

Review 1.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 2.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

3.  Fat and cardiotoxicity in hereditary pulmonary hypertension.

Authors:  Rubin M Tuder; Jeffrey C Robinson; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

4.  Spleen size in idiopathic and heritable pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Ruchi Yadav; Amit Gupta; Andrea V Arrossi; Gustavo A Heresi; Raed A Dweik
Journal:  Respiration       Date:  2012-08-03       Impact factor: 3.580

Review 5.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

6.  Adventitial alterations are the main features in pulmonary artery remodeling due to long-term chronic intermittent hypobaric hypoxia in rats.

Authors:  Julio Brito; Patricia Siques; Silvia M Arribas; Angel L López de Pablo; M Carmen González; Nelson Naveas; Karem Arriaza; Karen Flores; Fabiola León-Velarde; Ruth Pulido; Stefany Ordenes; M Rosario López
Journal:  Biomed Res Int       Date:  2015-02-08       Impact factor: 3.411

7.  Acute right heart failure caused by iatrogenic brachiocephalic arteriovenous fistula following orthopedic surgery.

Authors:  Kye Hun Kim; Hyun Ju Yoon; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean J Intern Med       Date:  2014-06-27       Impact factor: 2.884

8.  Functional assessment of the dynamic profile of tricuspid annular motion.

Authors:  Angel López-Candales
Journal:  Heart Views       Date:  2013-10

9.  Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?

Authors:  Nicole Lüneburg; Patricia Siques; Julio Brito; Karem Arriaza; Eduardo Pena; Hans Klose; Fabiola Leon-Velarde; Rainer H Böger
Journal:  Pulm Med       Date:  2016-05-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.